I just wrote to the CEO of @VertexPharma urging her to stop denying access to lifesaving #cysticfibrosis treatment. Thousands of patients are being left to suffer & die because of Vertex's staggering $326,000 price tag! Take action here: https://t.co/JbYMc8q6Iv #RightToBreathe
Today at the Brazilian Cystic Fibrosis Congress a protest was held at the @VertexPharma stand. Participants are demanding that they lower their prices and enable access to #Trikafta in Brazil and around the world. The global CF community is united and demand action now 👊💊🌎
On #WorldHealthDay please join us and sign the petition if you agree that every #cysticfibrosis patient, everywhere should have access to lifesaving drugs. No family should have to watch their loves-ones suffer and die when lifesaving drugs exist.
🔻🔻🔻
https://t.co/PGx7P7uZYQ
https://t.co/3LD0PID9bi
Some awesome news here! This is what we were campaigning for. A life unlimited by #cysticfibrosis.
@VertexPharma MUST make global access its priority. #CFcantwait.
Chelsea Stahl (Spruance) was afraid she wouldn’t get married because of her cystic fibrosis. She shared three approaches that helped her manage her CF while celebrating her dream wedding. https://t.co/U4hdfRbGyg
@VertexPharma@UNCF Can't see any commitment to patients of cystic fibrosis. You got Trikafta but not making it available to the patients in need. Anyway your commitment to profit over life patients can be seen. #cysticfibrosis@CF_Foundation
US company @VertexPharma is charging up to $326k a year for lifesaving #cysticfibrosis medicine - leaving thousands to suffer & die without treatment. I've just signed this petition demanding global access to CF drugs now - join me & add your name! https://t.co/MMgNOa4ND6
@PMOIndia @ORDI @Cipla_Global , @SunPharma_Live , @LupinGlobal, @Bharathbiotech Win-win Business Opportunity.
Vertex produces and sells CF meds for exorbitant cost. Many from non first world countries suffer and do not have access to these drugs which are out of patients reach.
@mansukhmandviya Sir Please look for access of life saving drug Trikafta by @VertexPharma to Indian Patients of. Cystic Fibrosis. They have taken marketing permission and haven't launched the medicine in India. Also, Vertex set price so high that Indian patients can't afford @MoHFW_INDIA
@Cipla_Global , @SunPharma_Live , @LupinGlobal, @Bharathbiotech Win-win Business Opportunity.
Vertex produces and sells CF meds for exorbitant cost. Many from non first world countries suffer and do not have access to these drugs which are out of patients #Indianpharamapickitup.
“It is not for the pharma industry to decide who lives and who dies in order to maximise its profits” 👏
Thanks @MedsLawPolicy for this write-up of our Right to Breathe campaign: https://t.co/W18XNSOBRp
We demand global access to lifesaving #cysticfibrosis treatment NOW! 🌍
"The cost of the #cysticfibrosis medicine that his 2-year-old started taking was about to climb from just $180 to a whopping $43,600 in 2023... due to a decision by @VertexPharma to slash the amount of financial assistance that it offers"
READ MORE👇
https://t.co/Di0smDRAHL
US company @VertexPharma is charging up to $326k a year for lifesaving #cysticfibrosis medicine - leaving thousands to suffer & die without treatment. I've just signed this petition demanding global access to CF drugs now - join me & add your name! https://t.co/SDMkiYhUCf
Read: 📚
"One company holds a monopoly on the manufacture and sale of CFTR modulator therapies and is choosing not to make new CF treatments available to people in the developing world through the normal channels..."
- that co. is @VertexPharma
Link:📲
https://t.co/0UUq0U4xOf